secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0001384101-22-000121
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte appoints Eliav Barr, M.D. to board of directors, effective August 9, 2022
--------------------------------------------------------------------------------

- Dr. Barr appointed as Class III director with term expiring at 2025 annual meeting.
- Also appointed to the Regulatory and Compliance Committee of the board.
- Receives annual cash retainer of $40,000 plus $5,000 for committee service.
- Initial restricted stock unit grant valued at $500,000, vesting over three years.
- Enters standard indemnification agreement for non-executive directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410122000121/0001384101-22-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410122000121/vcyt-20220809.htm
  HTML page:      https://secwatch.observer/filing/0001384101-22-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer